Objective: To compare the use of cycloprovera and HRP 102 (exposed group) with depomedroxy progesterone acetate (as control) in terms of bleeding pattern, continuation rate and body weight changes. Design/Data identification: Rondomized clinical trial. Material and method: Healthy women, 18-35 years of age, having at least one child, showed normal period during the last three months, did not ta…